- Brick-by-brick, India is restoring clinical trials 'parity'
- Is the Indian clinical trials segment pick up a mirage?
- Experts slam crippling Indian trial regulations
- India set to temper trial compensation rules
- Profile: Novartis India boss on a working mother, karma & his wrist watch
- Innovation not M&A to drive Bayer growth in LatAm
JOB OF THE WEEK Promote your job vacancy